Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Am J Gastroenterol ; 118(7): 1289-1292, 2023 07 01.
Article in English | MEDLINE | ID: mdl-36757720

ABSTRACT

The epidemiology of cirrhosis among immigrants to North America has not been described. Using population-level data from Ontario, Canada, recent immigrant and refugees with incident cirrhosis were identified and stratified by World Bank region of origin and cirrhosis etiology. Incidence rates were described based on region of origin and etiology and compared with those in Canadian-born/long-term residents. A total of 25,054 immigrants/refugees were identified with rates of cirrhosis lower compared with those in Canadian-born/long-term residents for all etiologies except hepatitis B virus likely explained by the healthy immigrant effect. Nonalcoholic fatty liver disease was the most common etiology of cirrhosis among immigrants and refugees.


Subject(s)
Emigrants and Immigrants , Refugees , Humans , Ontario/epidemiology , Canada , Incidence , North America
2.
Cardiovasc Revasc Med ; 37: 120-127, 2022 04.
Article in English | MEDLINE | ID: mdl-34334335

ABSTRACT

Timely reperfusion using primary percutaneous coronary intervention (pPCI) is the cornerstone of acute ST-elevation myocardial infarction (STEMI) management. We conducted a systematic review to examine the effect of sex on door-to-balloon (D2B) time and symptom-to-balloon (S2B) time. We observed longer D2B times and S2B times in female patients presenting with STEMI and referred for pPCI when compared to male patients. Future work is required to try and elucidate and mitigate sex-based front-line treatment delays for female STEMI patients.


Subject(s)
Percutaneous Coronary Intervention , ST Elevation Myocardial Infarction , Female , Humans , Male , ST Elevation Myocardial Infarction/diagnostic imaging , ST Elevation Myocardial Infarction/therapy , Time Factors , Treatment Outcome
3.
Cardiovasc Revasc Med ; 30: 78-84, 2021 09.
Article in English | MEDLINE | ID: mdl-33139220

ABSTRACT

Transcatheter Mitral Valve Repair (TMVr) offers clinically significant benefit to select symptomatic patients with severe mitral regurgitation (MR). We conducted a systematic review and meta-analysis of clinical trials and observational studies to identify the effect of pre-procedural Chronic Kidney disease (CKD) on short-term mortality in TMVr. We found CKD is a predictor of 30-day mortality in patients undergoing TMVr. Specifically, a GFR < 30 mL/min conveys a significant increase in 30-day mortality. This is significant for patient selection, prognostication, as well as identifies an area of need for further research. SUMMARY FOR ANNOTATED TABLE OF CONTENTS: A systematic review and meta-analysis looking at short-term mortality in patients undergoing Transcatheter Mitral Valve Repair with chronic kidney disease. Findings show severe renal disease is associated with increased 30-day mortality.


Subject(s)
Heart Valve Prosthesis Implantation , Mitral Valve Insufficiency , Renal Insufficiency, Chronic , Cardiac Catheterization/adverse effects , Heart Valve Prosthesis Implantation/adverse effects , Humans , Mitral Valve/diagnostic imaging , Mitral Valve/surgery , Mitral Valve Insufficiency/diagnostic imaging , Mitral Valve Insufficiency/surgery , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/therapy , Treatment Outcome
4.
Clin Liver Dis (Hoboken) ; 22(5): 167-170, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38026123
SELECTION OF CITATIONS
SEARCH DETAIL